Juha-Matti Savola

Years Active: 2022-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas-Antonios Roussakis, Marta Gennaro, Mark Forrest Gordon, Ralf Reilmann, Beth Borowsky, Gail Rynkowski, Nicholas P Lao-Kaim, Zoe Papoutsou, Juha-Matti Savola, Michael R Hayden, David R Owen, Nicola Kalk, Anne Lingford-Hughes, Roger N Gunn, Graham Searle, Sarah J Tabrizi, Paola Piccini
A PET-CT study on neuroinflammation in Huntington's disease patients participating in a randomized trial with laquinimod. Brain communications 5 (2) (2023)
Samuel Frank, Claudia Testa, Mary C Edmondson, Jody Goldstein, Elise Kayson, Blair R Leavitt, David Oakes, Christine O'Neill, Christina Vaughan, Jacquelyn Whaley, Nicholas Gross, Mark Forrest Gordon, Juha-Matti Savola, null null
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study. CNS drugs 36 (11) (2022)

Juha-Matti Savola.css-eqlu8i{font-size:small;padding-left:4px;}